Mittie Doyle
Vermögen: 956 820 $ am 30.06.2026
Vermögen: 956 820 $ am 30.06.2026
Dr. Mittie Doyle, MD, is a Chief Medical Officer at Avalo Therapeutics, Inc. She is on the Board of Directors at Cullinan Therapeutics, Inc. and Santa Ana Bio, Inc. Dr. Doyle was previously employed as an Independent Director by DICE Therapeutics, Inc., a Chief Medical Officer by Aro Biotherapeutics Co., a VP-Global Therapeutic, Head-Research & Development by CSL Behring LLC, a Vice President-Global Development Lead by Shire Pharmaceuticals, Inc., a Vice President-Clinical Research by Flexion Therapeutics, Inc., and a Senior Medical Director by Alexion Pharmaceuticals, Inc. She received her undergraduate degree from Princeton University and a doctorate degree from Yale School of Medicine.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 27.07.2026 | 51.776 ( 0,1 % ) | 956 820 $ | 30.06.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| AVALO THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 15.07.2024 |
| CULLINAN THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 07.08.2025 |
Santa Ana Bio, Inc.
Santa Ana Bio, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which focuses on precision immunology for autoimmune diseases | Direktor/Vorstandsmitglied | - |
| Unternehmen | Position | Ende |
|---|---|---|
Aro Biotherapeutics Co.
Aro Biotherapeutics Co. BiotechnologyHealth Technology Operates as a biotechnology company which focuses on the research and development of a new generation of protein biologics | Technik-/Wissenschafts-/F&E-Leiter | 01.07.2024 |
| DICE THER | Direktor/Vorstandsmitglied | 09.08.2023 |
CSL Behring LLC
CSL Behring LLC BiotechnologyHealth Technology Manufactures and markets plasma protein products | Technik-/Wissenschafts-/F&E-Leiter | 01.10.2021 |
Shire Pharmaceuticals, Inc.
Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 01.10.2017 |
| FLEXION THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.08.2016 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 11 |
|---|---|
Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops life-changing therapies for people living with rare disorders | Health Technology |
Flexion Therapeutics, Inc.
Flexion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes therapies for the treatment of patients with musculoskeletal conditions | Health Technology |
Princeton University
Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CSL Behring LLC
CSL Behring LLC BiotechnologyHealth Technology Manufactures and markets plasma protein products | Health Technology |
Shire Pharmaceuticals, Inc.
Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Avalo Therapeutics, Inc.
Avalo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics for patients with unmet clinical need in immunology and rare genetic diseases | Health Technology |
Yale School of Medicine
Yale School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
DICE Therapeutics, Inc.
DICE Therapeutics, Inc. BiotechnologyHealth Technology Develops oral immunology and other therapeutic products | Health Technology |
Aro Biotherapeutics Co.
Aro Biotherapeutics Co. BiotechnologyHealth Technology Operates as a biotechnology company which focuses on the research and development of a new generation of protein biologics | Health Technology |
Cullinan Oncology, Inc.
Cullinan Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Santa Ana Bio, Inc.
Santa Ana Bio, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which focuses on precision immunology for autoimmune diseases | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen